The Devil Is in the Due Diligence
In just a couple of weeks, MedTech Intelligence is hosting the MedTech Due Diligence conference in Boston. We’re bringing together a mix of didactic sessions with discussions, breakout working groups, and case studies, led by senior professionals who have gone through mergers and acquisitions and seen both the good and the bad, focuses on those issues unique to medical technology companies. Here are five reasons you need to come to the program in Boston:
- Meet top level speakers who have been through it all
- Identify the hidden areas where problems occur
- Learn best practices for performing due diligence
- Understand how to analyze and apply the due diligence results
- Learn from others’ successes and mistakes
MedTech Due Diligence Conference, July 14-15, 2016 | Boston, MA | LEARN MORE
Related Articles
-
Beginning October 1, 2023, the FDA’s Total Product Life Cycle Advisory Program (TAP) Pilot will expand to include the Office of Neurological and Physical Medicine Devices (OHT5).
-
“We are honored to have Dr. Lace, who is widely recognized as one of the industry’s most trusted reimbursement experts, leading our new division. He will also support all our services as our CMO.”
-
The acquisition expands Veranex’s footprint for product design engineering services across the U.S., with combined company offices now in the Eastern, Central, and Western regions
-
The acquisition brings MAXIS’ expertise in pre-clinical engineering, design validation and verification, regulatory affairs, field clinical services, and trial management to Avania’s contract research and MedTech development capabilities.
About The Author
Thomas Maeder
Senior Editor
Until March 2010, Tom served as Executive Director of the Medical Technology Learning Institute (MTLI), the education arm of AdvaMed, the world’s largest trade association representing the medical device and diagnostics industries, where he created and ran workshops and conferences on regulatory, reimbursement, and other practical topics important to device, diagnostics, and combination product manufacturers. Prior to joining AdvaMed, Tom was Senior Advisor for Scientific Strategies at Georgetown University Medical Center, Senior Science Writer and Philadelphia Bureau Chief of Red Herring, a technology-oriented national business magazine, the Research and Creative Director for a graphic and industrial design firm specializing in medical products and services, and an independent marketing and educational consultant to pharmaceutical, biotech, and medical device firms. He is the author of five books on topics including literary biography, the law, psychiatry, and the history of the pharmaceutical industry, has co-authored seven humor books, and has written many articles for magazines and newspapers including the Atlantic Monthly, Scientific American, The New York Times, and The Washington Post. He has done exhibition concept design and master plans for several U.S. science museums, and created the internationally traveling exhibit Salt of the Earth. Tom has a degree from Columbia University and did graduate work in developmental neurobiology at the University of Pennsylvania.